ABT Valuation

Abbott Laboratories

Add to Watchlist

Advanced Chart

131.630

-0.300(-0.230%)

Overview
Forecast
Valuation

ABT Relative Valuation

ABT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ABT is overvalued; if below, it's undervalued.

Historical Valuation

Abbott Laboratories(ABT) is now in theFairzone, suggesting that its currentforward PEratio of25.74is consideredFairlycompared with the five-year average of24.92.The fair price of Abbott Laboratories(ABT)is between129.98to150.28according to relative valuation methord.

Relative Value

Fair Zone

129.98-150.28

Current Price：131.63

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

4.81

P/B

Median3y

5.01

Median5y

5.46

2.78

FCF Yield

Median3y

3.27

Median5y

3.28

Competitors Valuation Multiple

The average P/S ratio for ABT's competitors is 7.99, providing a benchmark for relative valuation. Abbott Laboratories Corp (ABT) exhibits a P/S ratio of 5.16, which is -35.49% above the industry average. Given its robust revenue growth of 7.16%, this premium appearsunsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap